Tag Archives: The Stem Cell Blog

IsoPlexis research offers hope for targeted CAR-T treatment – The Pharma Letter (registration)

Continue reading

2017-04-07 NEWS

IsoPlexis research offers hope for targeted CART treatment
The Pharma Letter (registration)
US-based biotech firm IsoPlexis has presented findings from research using the company’s precision engineering platform, called IsoCode. The data show the potential to predict whether cancer patients will respond to CART cell therapy prior to

Continue reading

2017-04-07 NEWS

Slate Magazine

The synthetic biology community is divided on intellectual property.
Slate Magazine
As with many new fields, synthetic biology—which incorporates disparate disciplines like engineering, computer science, biotechnology, and molecular bi …
Synthetic Biology Market to Exceed US$ 38 Billion Globally by 2020MilTech

all 2 news articles »

Continue reading

2017-04-07 NEWS

Spectrum

Preprint peek-a-boo; vexing vacancy; CRISPR conundrum
Spectrum
More and more biologists are posting their papers on preprint servers, making their findings public before they’ve been through the drawn-out process of peer review. Not all journal publishers welcomed this new culture of openness at first, but most

Continue reading

2017-04-07 NEWS

BioPharma-Reporter.com

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com
Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal.
Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release)

all 3 news articles »

Continue reading

2017-04-07 NEWS

BioPharma-Reporter.com

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com
Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal.
Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release)

all 3 news articles »